Breaking News Instant updates and real-time market news.

RXDX

Ignyta

$6.25

-0.1 (-1.57%)

07:55
12/01/16
12/01
07:55
12/01/16
07:55

Ignyta to hold a conference call

In conjunction with the Company's presentations at the 2016 EORTC-NCI-AACR Symposium, management provides a substantial Phase 1b clinical data update of RXDX-105, as well as RXDX-106, on a conference call to be held on December 1 at 8 am. Webcast Link

  • 01

    Dec

RXDX Ignyta
$6.25

-0.1 (-1.57%)

04/18/16
PIPR
04/18/16
NO CHANGE
Target $32
PIPR
Overweight
Ignyta remains a top pick at Piper Jaffray
Piper Jaffray analyst Joshua Schimmer says Ignyta (RXDX) remains a top pick after the company over the weekend reported additional data from the ongoing entrectinib Phase 1 ALKA and STARTRK studies. The data continue to highlight the clinical activity in solid tumors as well as a generally tolerable profile, Schimmer tells investors in a research note. Loxo Oncology (LOXO) also reported Phase 1 data for an NTRK inhibitor, and the two drugs "appear fairly similar," the analyst contends. Schimmer believes this should help drive positive sentiment for Ignyta since there was investor concern that the Loxo data would appear superior. He keeps an Overweight rating on Ignyta with a $32 price target.
04/18/16
LEER
04/18/16
NO CHANGE
LEER
Outperform
Ignyta entrectinib continues to show 'encouraging' efficacy, says Leerink
Leerink analyst Paul Matteis says Ignyta's (RXDX) entrectinib continues to show "encouraging" efficacy and safety in an expanding sample of treated patients, following updated Phase 1 data presented by the company. The analyst says entrectinib shows "strong efficacy" in ROS1 with an 86% response rate, an 85% response rate in non-small cell lung cancer and multiple responses past 18 months. Loxo Oncology's (LOXO) LOXO-101, a competing inhibitor, also showed "nice efficacy data" with a comparable response rate, Matteis tells investors in a research note. The analyst reiterates an Outperform rating on Ignyta's shares.
05/11/16
PIPR
05/11/16
NO CHANGE
Target $32
PIPR
Overweight
Piper still surprised by Ignyta's 'modest valuation'
Piper Jaffray analyst Joshua Schimmer says he remains surprised by Ignyta's "modest valuation" given the company's "multiple attractive assets." Ignyta reported Q1 results last night provided some useful updates on entrectinib and taladegib, Schimmer tells investors in a research note. He keeps an Overweight rating on the shares with a $32 price target.
06/23/16
JPMS
06/23/16
INITIATION
Target $15
JPMS
Overweight
Ignyta initiated with an Overweight at JPMorgan
JPMorgan analyst Anupam Rama started Ignyta with an Overweight rating and $15 price target, saying the company's lead program entrectinib is underappreciated from both a clinical and commercial perspective. Rama also views taladegib and RXDX-105 as interesting assets and potential long-term value drivers, though they are not currently included in the valuation model used to arrive at the $15 target.

TODAY'S FREE FLY STORIES

VFC

VF Corp.

$57.14

1.35 (2.42%)

15:36
12/05/16
12/05
15:36
12/05/16
15:36
Technical Analysis
VF Corp. rises, rounding bottom pattern »

The stock is up over 2.3%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYGN

Myriad Genetics

$16.66

0.02 (0.12%)

15:30
12/05/16
12/05
15:30
12/05/16
15:30
Options
Vote of confidence in Myriad Genetics will result in big open interest increase »

Vote of confidence in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

SMTC

Semtech

$30.30

1.2 (4.12%)

15:25
12/05/16
12/05
15:25
12/05/16
15:25
Conference/Events
Semtech management to meet with B. Riley »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 07

    Dec

MMI

Marcus & Millichap

$27.78

0.49 (1.80%)

15:25
12/05/16
12/05
15:25
12/05/16
15:25
Hot Stocks
Marcus & Millichap's IPA unit closes sale of Isle at Arrowhead Ranch for $42M »

Marcus & Millichap…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 07

    Dec

15:25
12/05/16
12/05
15:25
12/05/16
15:25
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

RDI

Reading International

$15.76

-0.17 (-1.07%)

15:24
12/05/16
12/05
15:24
12/05/16
15:24
Conference/Events
Reading International management to meet with B. Riley »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 07

    Dec

ON

ON Semiconductor

$11.12

0.15 (1.37%)

15:22
12/05/16
12/05
15:22
12/05/16
15:22
Conference/Events
ON Semiconductor management to meet with B. Riley »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

SUP

Superior Industries

$25.43

0.725 (2.94%)

15:20
12/05/16
12/05
15:20
12/05/16
15:20
Conference/Events
Superior Industries management to meet with B. Riley »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 06

    Dec

  • 07

    Dec

  • 10

    Jan

VFC

VF Corp.

$57.11

1.315 (2.36%)

15:20
12/05/16
12/05
15:20
12/05/16
15:20
Options
5X average daily option volume in VFC driven by a three-way spread »

5X average daily option…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AIQ

Alliance HealthCare

15:16
12/05/16
12/05
15:16
12/05/16
15:16
Hot Stocks
Alliance HealthCare Radiology forms partnership with Sodexo Healthcare »

Alliance HealthCare…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

15:16
12/05/16
12/05
15:16
12/05/16
15:16
Technical Analysis
NYSE market internals summary »

Breadth is bullish across…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

15:16
12/05/16
12/05
15:16
12/05/16
15:16
Technical Analysis
NASDAQ market internals summary »

Volume is heavier than…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STO

Statoil

$17.74

0.025 (0.14%)

, BP

BP

$35.59

0.11 (0.31%)

15:15
12/05/16
12/05
15:15
12/05/16
15:15
Periodicals
Statoil, BP, Total group awarded first block in Salina auction, Reuters says »

Mexico has awarded a…

STO

Statoil

$17.74

0.025 (0.14%)

BP

BP

$35.59

0.11 (0.31%)

TOT

Total

$48.33

0.55 (1.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CCO

Clear Channel Outdoor

$5.55

-0.1 (-1.77%)

15:10
12/05/16
12/05
15:10
12/05/16
15:10
Hot Stocks
Clear Channel Airports awarded 10-year contract extension by MNAA »

Clear Channel Airports, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

T

AT&T

$38.78

0.1735 (0.45%)

, INTC

Intel

$34.16

0.4 (1.18%)

15:06
12/05/16
12/05
15:06
12/05/16
15:06
Hot Stocks
AT&T launches first 5G business customer trial with Intel and Ericsson »

AT&T (T) said it has…

T

AT&T

$38.78

0.1735 (0.45%)

INTC

Intel

$34.16

0.4 (1.18%)

ERIC

Ericsson

$5.16

0.04 (0.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 07

    Dec

  • 07

    Dec

  • 14

    Dec

  • 29

    Mar

LLL

L-3 Communications

$157.70

0.47 (0.30%)

15:03
12/05/16
12/05
15:03
12/05/16
15:03
Conference/Events
L-3 Communications to host investor meeting with conference call hookup »

Investor meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

PARR

Par Pacific

$15.19

0.2 (1.33%)

14:55
12/05/16
12/05
14:55
12/05/16
14:55
Hot Stocks
Whitebox Advisors cuts Par Pacific stake to 16.4% from 18.2% »

Whitebox Advisors, which…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:55
12/05/16
12/05
14:55
12/05/16
14:55
Conference/Events
U.S. Vice President Biden speaks on financial regulation »

Vice President Biden,…

GBT

Global Blood Therapeutics

$19.10

-0.1 (-0.52%)

14:55
12/05/16
12/05
14:55
12/05/16
14:55
Conference/Events
Global Blood Therapeutics to hold a webcast »

Management holds a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 14

    Dec

  • 15

    Dec

  • 19

    Dec

NEWM

New Media

$15.93

-0.06 (-0.38%)

, DTSI

DTS, Inc.

14:55
12/05/16
12/05
14:55
12/05/16
14:55
Hot Stocks
New Media to replace DTS, Inc. in S&P 600 as of 12/5 close »

S&P SmallCap 600…

NEWM

New Media

$15.93

-0.06 (-0.38%)

DTSI

DTS, Inc.

TSRA

Tessera

$39.30

0.2 (0.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBHC

National Bank

$29.99

0.835 (2.86%)

, ININ

Interactive Intelligence

14:55
12/05/16
12/05
14:55
12/05/16
14:55
Hot Stocks
National Bank to replace Interactive Intelligence in S&P 600 as of 12/5 close »

Genesys is acquiring…

NBHC

National Bank

$29.99

0.835 (2.86%)

ININ

Interactive Intelligence

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BDC

Belden

$74.55

0.46 (0.62%)

14:50
12/05/16
12/05
14:50
12/05/16
14:50
Hot Stocks
Belden CEO says targets long-term revenue growth 5%-7% »

Speaking during the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

IMGN

ImmunoGen

$1.88

0.11 (6.21%)

14:49
12/05/16
12/05
14:49
12/05/16
14:49
Hot Stocks
Breaking Hot Stocks news story on ImmunoGen »

ImmunoGen to submit IND…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COUP

Coupa Software

$26.29

-1.49 (-5.36%)

14:49
12/05/16
12/05
14:49
12/05/16
14:49
Options
Coupa Software options imply 19.3% move in share price post-earnings, below median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

IMGN

ImmunoGen

$1.88

0.11 (6.21%)

14:47
12/05/16
12/05
14:47
12/05/16
14:47
Hot Stocks
ImmunoGen reports preclinical data on IMGN632 presented at ASH meeting »

ImmunoGen announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.